Results 181 to 190 of about 45,320 (289)

A novel diagnostic serum protein signature for pediatric inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 5, Page 1208-1217, May 2026.
Abstract Objectives Diagnostic delay is common in pediatric inflammatory bowel disease (PIBD), and fecal calprotectin (FCP) is often limited by challenges with sample collection. Therefore, we aimed to identify and validate a blood‐based diagnostic protein signature of PIBD.
Charlotte Bache‐Wiig Mathisen, Niklas Nyström, Igor Bazov, Ove Øyås, Manuela Zucknick, Svend Andersen, Christine Olbjørn, Gøri Perminow, Vendel A. Kristensen, Randi Opheim, Mauro D'Amato, Marie Carlson, Charlotte R. H. Hedin, Åsa V. Keita, Carl Mårten Lindqvist, Maria K. Magnusson, Samira Salihovic, Johan D. Söderholm, Lena Öhman, Robert Kruse, Dirk Repsilber, Jonas Halfvarson, Marte Lie Høivik   +22 more
wiley   +1 more source

Transcolonic endoscopic appendectomy using a novel integrated snare-knife device: a case report. [PDF]

Endoscopy
Huang T, Chen F, Liu XY, Guo X, Zhou PH.
europepmc   +1 more source

Sentinel events in pediatric hepatology: A pilot simulation curriculum

JPGN Reports, Volume 7, Issue 2, Page 332-339, May 2026.
Abstract Objectives Sentinel hepatology events require robust prior experience to accurately diagnose and manage. Given the rarity of complex pediatric liver disease, gastroenterology (GI) fellows do not uniformly get exposure to these patients.
Anne Lyon, Alan Leichtner, Donna Luff, Scott Elisofon, Andrew Wehrman, Katherine Sweeny, Janet MacDonald, Christine K. Lee   +7 more
wiley   +1 more source

Novel needle system for transmural access in therapeutic endoscopic ultrasound. [PDF]

Endoscopy
Mazza S, Scalvini D, Mauro A, Bardone M, Alfieri D, Torello Viera F, Anderloni A.   +6 more
europepmc   +1 more source

Return to baseline arsenic concentrations after 1 year on gluten‐free diet in children with celiac disease: A prospective cohort study

JPGN Reports, Volume 7, Issue 2, Page 315-322, May 2026.
Abstract Objectives Lifelong adherence to a gluten‐free diet (GFD) is the primary treatment for celiac disease (CeD). Concerns have been raised about increased exposure to contaminants in a GFD because rice, which naturally bioaccumulates arsenic and other environmental contaminants, is commonly used as a substitute for gluten.
Nan Du, Clara Baek, Rachel Rosen, Tracy Punshon, Jocelyn A. Silvester   +4 more
wiley   +1 more source

Early diagnosis of colorectal cancer using Cerenkov luminescence endoscopy: a pilot trial involving humans for the first time. [PDF]

Theranostics
Yang Z, Wu Z, Pang T, Liu D, Wang X, Yu J, Xu S, Kang X, Liao D, Tian Z, Bai Y, Xi X, Yan T, Lu X, Qi Y, Zhang M, Zhao L, Kang F, Liang S, Wang J, Chen X, Wu K.   +21 more
europepmc   +1 more source

Utility of Fecal Elastase‐1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review

Pediatric Pulmonology, Volume 61, Issue 5, May 2026.
ABSTRACT Background In people with cystic fibrosis (pwCF), identification of exocrine pancreatic insufficiency (EPI) is essential to prevent steatorrhea and, if not managed actively, can lead to catastrophic consequences. Fecal elastase‐1 (FE‐1) is a widely used test to screen for EPI in cystic fibrosis (CF).
Senthilkumar Sankararaman, Sara Hendrix, Mandy Neudecker, Drucy Borowitz   +3 more
wiley   +1 more source

Expert consensus on multidisciplinary management of laparoscopic-endoscopic cooperative surgery combined with sentinel lymph node navigation surgery for early gastric cancer (2026 edition). [PDF]

Chin J Cancer Res
Zheng Z, Zhao Y, Xu R, Wang Z, Yin J, Meng F, Liu K, Chen G, Zhang J, Li P, Chen L, Zhang Z, Zhang S, Digestive Diseases NCRCF, Digestive Health NKLO, Chinese Medical Association DEBO, Chinese Medical Doctor Association GAHBO, Of China Anti-Cancer Association CGCA.   +17 more
europepmc   +1 more source

Diagnostic value of confocal laser endoscopy in digestive system diseases

World Chinese Journal of Digestology, 2008
openaire   +1 more source

Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis

United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
ABSTRACT Background Mirikizumab demonstrated efficacy in moderately‐to‐severely active ulcerative colitis, including in patients with prior advanced therapy failure (PATF) (Phase 3: LUCENT‐1 [NCT03518086], LUCENT‐2 [NCT03524092]). This post hoc analysis evaluates mirikizumab efficacy by number/mechanism of PATF.
Ailsa Hart, Seyedehsan Navabi, Geert D'Haens, Katsuyoshi Matsuoka, María Dolores Martín‐Arranz, Raja Atreya, Karen Hamrick Samaan, Endip Dhesi, Isabel Redondo, Baojin Zhu, Jerome Paulissen, Liliana Zaremba‐Pechmann, Simin Baygani, Jimmy Limdi, David Laharie, Silvio Danese   +15 more
wiley   +1 more source